Rx to OTC Switches Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Rx to OTC Switches Market is expected to grow at a CAGR of 5% during the forecast period of 2022-2028.

Changing the marketing status of a drug from prescription (Rx) to over-the-counter (OTC) is called the Rx-to-OTC switch. Scientifically, this is a rigorous and highly regulated process that allows consumers to purchase OTC access to a growing variety of pharmaceuticals. Drugs licensed over-the-counter must comply with regulatory standards related to drug efficacy, have a wide margin of safety to ensure proper use of the product, and have strong labeling. The shift from Rx to OTC is gaining momentum as OTC drugs are cost-effective and provide first-line treatment for a number of common diseases. The result is fewer doctor visits and consequently more sales opportunities in the marketplace.

Market Segments

By Drug Category

• Allergy and Respiratory
• Fungal Infections & Other Infections
• Overactive Bladder
• Oral Contraceptives
• Gastrointestinal Drugs
• Hair Loss Treatments
• Smoking Cessation
• Analgesic, Inflammation And Pain Management
• Others (Lice, Acne, Weight Loss, And Laxative)

Key Players

• GlaxoSmithKline plc.
• Astrazeneca, Merck KGaA
• Johnson & Johnson
• Bayer AG
• Sanofi
• Boehringer Ingelheim Consumer Healthcare
• Bausch and Lomb (A Subsidiary of Bausch Health)
• Galderma SA

Scope of the Report

The research study analyzes the global Rx to OTC Switches industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Rx to OTC Switches Market Report

1. What was the Rx to OTC Switches Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Rx to OTC Switches Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Rx to OTC Switches Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.